Equities
  • Price (EUR)0.3192
  • Today's Change-0.008 / -2.39%
  • Shares traded2.00k
  • 1 Year change-35.55%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 18:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year NOVONIX Ltd had net income fall 65.98% from a loss of 27.86m to a larger loss of 46.25m despite revenues that grew 166.94% from 3.02m to 8.05m over the same period.
Gross margin-227.66%
Net profit margin-600.33%
Operating margin-639.44%
Return on assets-17.96%
Return on equity-26.03%
Return on investment-18.52%
More ▼

Cash flow in USDView more

In 2023, cash reserves at NOVONIX Ltd fell by 20.33m. Cash Flow from Financing totalled 29.31m or 363.89% of revenues. In addition the company used 36.23m for operations while cash used for investing totalled 11.74m.
Cash flow per share-0.1261
Price/Cash flow per share--
Book value per share0.4744
Tangible book value per share0.4385
More ▼

Balance sheet in USDView more

NOVONIX Ltd has a Debt to Total Capital ratio of 31.22%, a lower figure than the previous year's 33.48%.
Current ratio6.15
Quick ratio5.94
Total debt/total equity0.4538
Total debt/total capital0.3122
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.